Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Small for size syndrome difficult dilemma: Lessons from 10 years single centre experience in living donor liver transplantation.

Shoreem H, Gad EH, Soliman H, Hegazy O, Saleh S, Zakaria H, Ayoub E, Kamel Y, Abouelella K, Ibrahim T, Marawan I.

World J Hepatol. 2017 Jul 28;9(21):930-944. doi: 10.4254/wjh.v9.i21.930.

2.

Suicidal Ideation in an Egyptian Sample of Hospitalized Patients with Acute Psychosis.

Ftouh M, Gad ES, Seleem MA, Saada S, Mubarak AA.

Clin Schizophr Relat Psychoses. 2017 Aug 4. doi: 10.3371/CSRP.MFEG.071317. [Epub ahead of print]

PMID:
28777032
3.

Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells In Vivo.

Cecil DL, Slota M, O'Meara MM, Curtis BC, Gad E, Dang Y, Herendeen D, Rastetter L, Disis ML.

Clin Cancer Res. 2017 Jul 1;23(13):3396-3404. doi: 10.1158/1078-0432.CCR-16-1678. Epub 2016 Dec 30.

4.

Glomerular Glucocorticoid Receptors Expression and Clinicopathological Types of Childhood Nephrotic Syndrome.

Gamal Y, Badawy A, Swelam S, Tawfeek MS, Gad EF.

Fetal Pediatr Pathol. 2017 Feb;36(1):16-26. doi: 10.1080/15513815.2016.1225872. Epub 2016 Oct 3.

PMID:
27690709
5.

Pioglitazone and exenatide enhance cognition and downregulate hippocampal beta amyloid oligomer and microglia expression in insulin-resistant rats.

Gad ES, Zaitone SA, Moustafa YM.

Can J Physiol Pharmacol. 2016 Aug;94(8):819-28. doi: 10.1139/cjpp-2015-0242. Epub 2015 Dec 16.

PMID:
27389824
6.

Hepatic arterial and portal venous complications after adult and pediatric living donor liver transplantation, risk factors, management and outcome (A retrospective cohort study).

Gad EH, Abdelsamee MA, Kamel Y.

Ann Med Surg (Lond). 2016 Apr 29;8:28-39. doi: 10.1016/j.amsu.2016.04.021. eCollection 2016 Jun.

7.

The Antitumor Efficacy of IL2/IL21-Cultured Polyfunctional Neu-Specific T Cells Is TNFα/IL17 Dependent.

Phan-Lai V, Dang Y, Gad E, Childs J, Disis ML.

Clin Cancer Res. 2016 May 1;22(9):2207-16. doi: 10.1158/1078-0432.CCR-15-2273. Epub 2015 Dec 9.

8.

Epidermal growth factor receptor derived peptide vaccination to prevent lung adenocarcinoma formation: An in vivo study in a murine model of EGFR mutant lung cancer.

Ebben JD, Lubet RA, Gad E, Disis ML, You M.

Mol Carcinog. 2016 Nov;55(11):1517-1525. doi: 10.1002/mc.22405. Epub 2015 Sep 7.

9.

Complications and mortality after adult to adult living donor liver transplantation: A retrospective cohort study.

Gad EH, Alsebaey A, Lotfy M, Eltabbakh M, Sherif AA.

Ann Med Surg (Lond). 2015 Apr 25;4(2):162-71. doi: 10.1016/j.amsu.2015.04.021. eCollection 2015 Jun.

10.

Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancer.

Liao JB, Ovenell KJ, Curtis EE, Cecil DL, Koehnlein MR, Rastetter LR, Gad EA, Disis ML.

J Immunother Cancer. 2015 May 19;3:16. doi: 10.1186/s40425-015-0060-6. eCollection 2015.

11.

Natural history of tumor growth and immune modulation in common spontaneous murine mammary tumor models.

Gad E, Rastetter L, Slota M, Koehnlein M, Treuting PM, Dang Y, Stanton S, Disis ML.

Breast Cancer Res Treat. 2014 Dec;148(3):501-10. doi: 10.1007/s10549-014-3199-9. Epub 2014 Nov 14.

12.

Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer.

Mao J, Ladd J, Gad E, Rastetter L, Johnson MM, Marzbani E, Childs JS, Lu H, Dang Y, Broussard E, Stanton SE, Hanash SM, Disis ML.

J Transl Med. 2014 May 10;12:121. doi: 10.1186/1479-5876-12-121.

13.

Elimination of IL-10-inducing T-helper epitopes from an IGFBP-2 vaccine ensures potent antitumor activity.

Cecil DL, Holt GE, Park KH, Gad E, Rastetter L, Childs J, Higgins D, Disis ML.

Cancer Res. 2014 May 15;74(10):2710-8. doi: 10.1158/0008-5472.CAN-13-3286. Epub 2014 Apr 28.

14.

Protein-bound polysaccharide-K induces IL-1β via TLR2 and NLRP3 inflammasome activation.

Yang Y, Inatsuka C, Gad E, Disis ML, Standish LJ, Pugh N, Pasco DS, Lu H.

Innate Immun. 2014 Nov;20(8):857-66. doi: 10.1177/1753425913513814. Epub 2013 Dec 9.

15.

A multiantigen vaccine targeting neu, IGFBP-2, and IGF-IR prevents tumor progression in mice with preinvasive breast disease.

Disis ML, Gad E, Herendeen DR, Lai VP, Park KH, Cecil DL, O'Meara MM, Treuting PM, Lubet RA.

Cancer Prev Res (Phila). 2013 Dec;6(12):1273-82. doi: 10.1158/1940-6207.CAPR-13-0182. Epub 2013 Oct 23.

16.

T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity.

Cecil DL, Park KH, Gad E, Childs JS, Higgins DM, Plymate SR, Disis ML.

Breast Cancer Res Treat. 2013 Jun;139(3):657-65. doi: 10.1007/s10549-013-2577-z. Epub 2013 Jun 8.

PMID:
23749321
17.

Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant.

Engel AL, Sun GC, Gad E, Rastetter LR, Strobe K, Yang Y, Dang Y, Disis ML, Lu H.

Immunobiology. 2013 Dec;218(12):1468-76. doi: 10.1016/j.imbio.2013.05.001. Epub 2013 May 13.

18.

Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK.

Inatsuka C, Yang Y, Gad E, Rastetter L, Disis ML, Lu H.

Cancer Immunol Immunother. 2013 Aug;62(8):1335-45. doi: 10.1007/s00262-013-1436-4. Epub 2013 May 18.

19.

Three-dimensional scaffolds to evaluate tumor associated fibroblast-mediated suppression of breast tumor specific T cells.

Phan-Lai V, Florczyk SJ, Kievit FM, Wang K, Gad E, Disis ML, Zhang M.

Biomacromolecules. 2013 May 13;14(5):1330-7. doi: 10.1021/bm301928u. Epub 2013 Apr 3.

20.

Substituent effects on the phenol coupling reaction catalyzed by the vancomycin biosynthetic P450 enzyme OxyB.

Schmartz PC, Wölfel K, Zerbe K, Gad E, El Tamany el S, Ibrahim HK, Abou-Hadeed K, Robinson JA.

Angew Chem Int Ed Engl. 2012 Nov 12;51(46):11468-72. doi: 10.1002/anie.201204458. Epub 2012 Oct 16. No abstract available.

PMID:
23073849
21.

Dendritic cell-activating vaccine adjuvants differ in the ability to elicit antitumor immunity due to an adjuvant-specific induction of immunosuppressive cells.

Dang Y, Wagner WM, Gad E, Rastetter L, Berger CM, Holt GE, Disis ML.

Clin Cancer Res. 2012 Jun 1;18(11):3122-31. doi: 10.1158/1078-0432.CCR-12-0113. Epub 2012 Apr 17.

22.

TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy.

Lu H, Yang Y, Gad E, Inatsuka C, Wenner CA, Disis ML, Standish LJ.

Clin Cancer Res. 2011 Nov 1;17(21):6742-53. doi: 10.1158/1078-0432.CCR-11-1142. Epub 2011 Sep 14.

23.

Neuroendocrinal study of depression in male epileptic patients.

Afifi S, Fadel W, Morad H, Eldod A, Gad E, Arfken CL, Samra A, Boutros N.

J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):163-7. doi: 10.1176/appi.neuropsych.23.2.163.

PMID:
21677244
24.

Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells.

Lu H, Yang Y, Gad E, Wenner CA, Chang A, Larson ER, Dang Y, Martzen M, Standish LJ, Disis ML.

Clin Cancer Res. 2011 Jan 1;17(1):67-76. doi: 10.1158/1078-0432.CCR-10-1763. Epub 2010 Nov 10.

25.

Treatment failure of a TLR-7 agonist occurs due to self-regulation of acute inflammation and can be overcome by IL-10 blockade.

Lu H, Wagner WM, Gad E, Yang Y, Duan H, Amon LM, Van Denend N, Larson ER, Chang A, Tufvesson H, Disis ML.

J Immunol. 2010 May 1;184(9):5360-7. doi: 10.4049/jimmunol.0902997. Epub 2010 Mar 22.

26.

Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer.

Park KH, Gad E, Goodell V, Dang Y, Wild T, Higgins D, Fintak P, Childs J, Dela Rosa C, Disis ML.

Cancer Res. 2008 Oct 15;68(20):8400-9. doi: 10.1158/0008-5472.CAN-07-5891.

27.

Edge enhancement and edge-enhanced correlation with photorefractive polymers.

Banerjee PP, Gad E, Hudson T, McMillen D, Abdeldayem H, Frazier D, Matsushita K.

Appl Opt. 2000 Oct 10;39(29):5337-46.

PMID:
18354530
28.

Displacement measurement that uses transient photoelectromotive force effects in CdTe:V with frequency-modulated lasers.

Jin F, Khurgin JB, Wang CC, Trivedi S, Gabay Y, Gad E, Temple DA, Hommerich UH.

Appl Opt. 2000 Jun 20;39(18):3138-42.

PMID:
18345244
29.
30.

The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity.

Behrens MD, Wagner WM, Krco CJ, Erskine CL, Kalli KR, Krempski J, Gad EA, Disis ML, Knutson KL.

Blood. 2008 Feb 1;111(3):1472-9. Epub 2007 Nov 20.

31.
32.

Immunoediting of cancers may lead to epithelial to mesenchymal transition.

Knutson KL, Lu H, Stone B, Reiman JM, Behrens MD, Prosperi CM, Gad EA, Smorlesi A, Disis ML.

J Immunol. 2006 Aug 1;177(3):1526-33.

33.
34.

Socio-demographic study of obsessive compulsive disorder in Qatar.

Gad EM, Shaltout TE.

Neurosciences (Riyadh). 2004 Oct;9(4):295-8.

PMID:
23377251
35.

A new algorithm for learning in piecewise-linear neural networks.

Gad EF, Atiya AF, Shaheen S, el-Dessouki A.

Neural Netw. 2000 May-Jun;13(4-5):485-505.

PMID:
10946395

Supplemental Content

Support Center